Comparing two fluids for removing surface esophageal tumors
Part of Cancer, Digestive system clinical trials.
This trial tests two different fluids (hyaluronic acid and hydroxyethylamide) used during a procedure to remove early-stage esophageal cancer. The goal is to see which fluid works better to help the doctor remove the tumor safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a superficial (early) tumor in the esophagus that has been confirmed as adenocarcinoma or squamous cell carcinoma.
- Your doctor has recommended a type of endoscopy called ESD to remove the tumor.
- You do not have a history of serious heart, kidney, or liver disease.
- You are not pregnant or breastfeeding, and have no allergy to hyaluronic acid.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at people (18 or older) who already had a digestive tract tumor removed using an endoscopy procedure. It may help doctors learn how this approach works and what outcomes to expect after removal.
This trial studies a specialized endoscopy procedure to remove larger abnormal growths in the upper digestive tract. It may help people whose lesion size and depth make certain removal techniques a better fit.
This trial tests if adding radiation therapy after endoscopic surgery (ESD) helps people with early-stage esophageal cancer that had certain high-risk features, like deeper invasion or positive margins. It aims to improve outcomes for those who didn't get a complete cure with surgery alone.
This trial tests a special stitching tool to close holes in the stomach after removing abnormal growths. It may help patients heal better after a routine procedure to remove suspicious tissue.
This study is for adults who need a procedure called endoscopic submucosal dissection to remove a lesion in the esophagus. Researchers will track outcomes to better understand how this treatment works in real-world settings.
This study compares two ways doctors remove abnormal tissue in the esophagus during endoscopy: EMR versus ESD. It may help improve how safely and completely these lesions are removed, while also comparing outcomes between the two methods.
Hear when a new Esophageal Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.